Rhumbline Advisers Lemaitre Vascular Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Rhumbline Advisers holds 74,836 shares of LMAT stock, worth $6.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
74,836
Previous 84,083 11.0%
Holding current value
$6.95 Million
Previous $6.92 Million 0.48%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$80.3 - $92.89 $742,534 - $858,953
-9,247 Reduced 11.0%
74,836 $6.95 Million
Q2 2024

Aug 01, 2024
SELL
$62.62 - $83.59 $169,512 - $226,278
-2,707 Reduced 3.12%
84,083 $6.92 Million
Q1 2024

May 09, 2024
SELL
$54.0 - $71.06 $47,682 - $62,745
-883 Reduced 1.01%
86,790 $5.76 Million
Q4 2023

Feb 08, 2024
SELL
$45.37 - $58.41 $95,912 - $123,478
-2,114 Reduced 2.35%
87,673 $4.98 Million
Q3 2023

Nov 09, 2023
SELL
$53.45 - $67.01 $481,744 - $603,961
-9,013 Reduced 9.12%
89,787 $4.89 Million
Q2 2023

Aug 08, 2023
BUY
$50.38 - $68.21 $65,846 - $89,150
1,307 Added 1.34%
98,800 $6.65 Million
Q1 2023

May 11, 2023
BUY
$44.73 - $51.68 $40,927 - $47,287
915 Added 0.95%
97,493 $5.02 Million
Q4 2022

Feb 14, 2023
BUY
$41.94 - $52.25 $85,431 - $106,433
2,037 Added 2.15%
96,578 $4.45 Million
Q3 2022

Nov 10, 2022
SELL
$45.29 - $55.99 $102,853 - $127,153
-2,271 Reduced 2.35%
94,541 $4.79 Million
Q2 2022

Aug 11, 2022
BUY
$39.05 - $47.85 $39,284 - $48,137
1,006 Added 1.05%
96,812 $4.41 Million
Q1 2022

May 12, 2022
BUY
$40.48 - $51.5 $294,127 - $374,199
7,266 Added 8.21%
95,806 $4.45 Million
Q4 2021

Feb 10, 2022
BUY
$46.66 - $56.25 $8,818 - $10,631
189 Added 0.21%
88,540 $4.45 Million
Q3 2021

Nov 12, 2021
SELL
$53.09 - $60.57 $29,358 - $33,495
-553 Reduced 0.62%
88,351 $4.69 Million
Q2 2021

Aug 05, 2021
SELL
$47.74 - $63.33 $215,784 - $286,251
-4,520 Reduced 4.84%
88,904 $5.43 Million
Q1 2021

May 06, 2021
SELL
$40.19 - $51.5 $1.23 Million - $1.58 Million
-30,643 Reduced 24.7%
93,424 $4.56 Million
Q4 2020

Feb 10, 2021
BUY
$31.44 - $41.27 $45,588 - $59,841
1,450 Added 1.18%
124,067 $5.03 Million
Q3 2020

Nov 12, 2020
SELL
$25.73 - $33.98 $1.77 Million - $2.33 Million
-68,713 Reduced 35.91%
122,617 $3.99 Million
Q2 2020

Aug 13, 2020
SELL
$22.88 - $30.71 $35,097 - $47,109
-1,534 Reduced 0.8%
191,330 $5.05 Million
Q1 2020

May 06, 2020
BUY
$21.03 - $38.46 $818,277 - $1.5 Million
38,910 Added 25.27%
192,864 $4.81 Million
Q4 2019

Feb 05, 2020
BUY
$31.27 - $36.21 $87,899 - $101,786
2,811 Added 1.86%
153,954 $5.54 Million
Q3 2019

Oct 23, 2019
BUY
$27.91 - $35.78 $1.32 Million - $1.69 Million
47,326 Added 45.59%
151,143 $5.17 Million
Q2 2019

Aug 14, 2019
BUY
$25.55 - $30.79 $377,220 - $454,583
14,764 Added 16.58%
103,817 $2.91 Million
Q1 2019

May 01, 2019
BUY
$22.45 - $31.55 $60,996 - $85,721
2,717 Added 3.15%
89,053 $2.76 Million
Q4 2018

Jan 31, 2019
BUY
$22.01 - $37.23 $183,365 - $310,163
8,331 Added 10.68%
86,336 $2.04 Million
Q3 2018

Nov 07, 2018
BUY
$34.02 - $38.74 $605,556 - $689,572
17,800 Added 29.57%
78,005 $3.02 Million
Q2 2018

Aug 06, 2018
BUY
$31.45 - $41.02 $63,371 - $82,655
2,015 Added 3.46%
60,205 $2.02 Million
Q1 2018

May 02, 2018
SELL
$30.5 - $37.13 $75,731 - $92,193
-2,483 Reduced 4.09%
58,190 $2.11 Million
Q4 2017

Feb 09, 2018
BUY
$30.9 - $39.01 $66,064 - $83,403
2,138 Added 3.65%
60,673 $1.93 Million
Q3 2017

Nov 06, 2017
BUY
$32.75 - $39.13 $1.92 Million - $2.29 Million
58,535
58,535 $2.19 Million

Others Institutions Holding LMAT

# of Institutions
291
Shares Held
20.4M
Call Options Held
5.2K
Put Options Held
2.9K
View Full List

About LEMAITRE VASCULAR INC

LMAT Quotes by TradingView
  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.04B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email